|
FY2025
12 months to Aug 31, 2025
|
FY2024
12 months to Aug 31, 2024
|
FY2023
12 months to Aug 31, 2023
|
FY2022
12 months to Aug 31, 2022
|
FY2021
12 months to Aug 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Research and development expense | |||||
| General and administrative expenses | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income | |||||
| Financial (loss) income, net | |||||
| Capital Gain (loss) | |||||
| Capital loss | |||||
| Financial loss, net | |||||
| Net (loss) income | |||||
| (Loss) Profit from available for sale assets | |||||
| Total comprehensive (loss) income | |||||
| Net (loss) per share - basic | |||||
| Net (loss) per share - diluted | |||||
| Weighted average number of shares outstanding - Basic | |||||
| Weighted average number of shares outstanding - Diluted | |||||
Loading...
